A Review of Chemical Tools for Studying Small Molecule Persulfides: Detection and Delivery

Author(s):  
Kearsley M. Dillon ◽  
John B. Matson
Author(s):  
Bin Yu ◽  
Zekun Du ◽  
Yuming Zhang ◽  
Zhiyu Li ◽  
Jinlei Bian

Proteolysis-targeting chimeras are a new modality of chemical tools and potential therapeutics involving the induction of protein degradation. Cyclin-dependent kinase (CDK) protein, which is involved in cycles and transcription cycles, participates in regulation of the cell cycle, transcription and splicing. Proteolysis-targeting chimeras targeting CDKs show several advantages over traditional CDK small-molecule inhibitors in potency, selectivity and drug resistance. In addition, the discovery of molecule glues promotes the development of CDK degraders. Herein, the authors describe the existing CDK degraders and focus on the discussion of the structural characteristics and design of these degraders.


2019 ◽  
Vol 10 (46) ◽  
pp. 10723-10727 ◽  
Author(s):  
Turner D. Newton ◽  
Michael D. Pluth

Hydrolysis-based H2Se donors provide new chemical tools for investigating biological H2Se.


2021 ◽  
Author(s):  
Frances M Potjewyd ◽  
Joel K Annor-Gyamfi ◽  
Jeffrey Aube ◽  
Shaoyou Chu ◽  
Ivie L Conlon ◽  
...  

Introduction: The portfolio of novel targets to treat Alzheimer's disease (AD) has been enriched by the AMP-AD program. Methods: A cheminformatics-driven effort enabled identification of existing small molecule modulators for many protein targets nominated by AMP-AD and suitable positive control compounds to be included in the set. Results: We have built an annotated set of 171 small molecule modulators, including mostly inhibitors, targeting 98 unique proteins that have been nominated by AMP-AD consortium members as novel targets for AD treatment. These small molecules vary in their quality and should be considered chemical tools that can be used in efforts to validate therapeutic hypotheses, but which would require further optimization. A physical copy of the AD Informer Set can be ordered via the AD Knowledge Portal. Discussion: Small molecule tools that enable target validation are important tools for the translation of novel hypotheses into viable therapeutic strategies for AD.


2014 ◽  
Vol 50 (40) ◽  
pp. 5301-5303 ◽  
Author(s):  
Masha G. Savelieff ◽  
Yuzhong Liu ◽  
Russell R. P. Senthamarai ◽  
Kyle J. Korshavn ◽  
Hyuck Jin Lee ◽  
...  

A small molecule was designed for reactivity toward Cu(ii)–amyloid-β over Zn(ii)–amyloid-β, which will expand on the development of chemical tools to uncover the role of metal–Aβ species in Alzheimer's disease.


2020 ◽  
Vol 56 (98) ◽  
pp. 15422-15425
Author(s):  
Shunsuke Sawada ◽  
Akinobu Nakamura ◽  
Tatsuyuki Yoshii ◽  
Keiko Kuwata ◽  
Fubito Nakatsu ◽  
...  

Synthetic molecules consisting of a small-molecule ligand and a tri-N-methylated myristoyl-Gly-Cys lipopeptide serve as chemical tools to rapidly recruit their target proteins from the cytoplasm to the Golgi surface in living cells.


2010 ◽  
Vol 8 (1) ◽  
pp. 11 ◽  
Author(s):  
Kerrie L Taylor ◽  
Nicola J Grant ◽  
Nicholas D Temperley ◽  
E. Elizabeth Patton

2020 ◽  
Vol 8 (43) ◽  
pp. 15135-15141
Author(s):  
Jing Yan ◽  
Yuan-Qiu-Qiang Yi ◽  
Jianqi Zhang ◽  
Huanran Feng ◽  
Yanfeng Ma ◽  
...  

Two non-fullerene small molecule acceptors, NT-4F and NT-4Cl, were designed and synthesized. Power conversion efficiencies of 11.44% and 14.55% were achieved for NT-4Cl-based binary and ternary devices, respectively.


Sign in / Sign up

Export Citation Format

Share Document